Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

  • Post published:July 21, 2021
  • Post category:Press Release
Read more about the article Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

  • Post published:July 13, 2021
  • Post category:Press Release
Read more about the article Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

  • Post published:June 24, 2021
  • Post category:Press Release
Read more about the article Mydecine Unveils Artificial Intelligence Drug Discovery Program

Mydecine Unveils Artificial Intelligence Drug Discovery Program

  • Post published:June 16, 2021
  • Post category:Press Release
Read more about the article Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

  • Post published:June 8, 2021
  • Post category:Press Release
Read more about the article Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

  • Post published:May 25, 2021
  • Post category:Press Release
Read more about the article Mydecine Provides Update on Spin-Out of U.S. Cannabis Assets

Mydecine Provides Update on Spin-Out of U.S. Cannabis Assets

  • Post published:May 19, 2021
  • Post category:Press Release
Read more about the article Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update

Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update

  • Post published:May 18, 2021
  • Post category:Press Release
Read more about the article Mydecine Announces Partnership with LeadGen Labs

Mydecine Announces Partnership with LeadGen Labs

  • Post published:May 5, 2021
  • Post category:Press Release
Read more about the article Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

  • Post published:May 3, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More